Related Experiment Video

Updated: Aug 7, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 10, 2014

Carboxanilide derivative non-nucleoside inhibitors of HIV-1 reverse transcriptase interact with different mechanistic

R S Fletcher1, K Syed, S Mithani

  • 1Lady Davis Institute for Medical Research, Sir Mortimer B. Davis- Jewish General Hospital, Montreal, Quebec, Canada.

Biochemistry
|April 4, 1995
PubMed

Insights

A new thiocarboxanilide derivative, UC38, shows stronger anti-HIV activity than UC84 by inhibiting HIV-1 reverse transcriptase (RT). UC38 and UC84 bind to different forms of RT, suggesting distinct mechanisms of action.

Area of Science:

  • Virology
  • Biochemistry
  • Medicinal Chemistry

Background:

  • Oxathiin carboxanilide (UC84) was identified as a potential anti-HIV compound.
  • HIV-1 reverse transcriptase (RT) is a key target for antiviral therapies.

Purpose of the Study:

  • To compare the inhibitory effects of UC84 and a novel thiocarboxanilide derivative, UC38, on HIV-1 RT activity.
  • To elucidate the binding mechanisms and interactions of UC84 and UC38 with HIV-1 RT.

Main Methods:

  • Enzyme inhibition assays were performed to determine IC50 values for UC84 and UC38 against HIV-1 RT RNA-dependent DNA polymerase activity.
  • Kinetic analyses were conducted to understand the inhibition patterns (competitive, uncompetitive, noncompetitive) with respect to primer/template (P/T) and deoxynucleoside triphosphate (dNTP).
  • Photoinactivation studies using an azido derivative of nevirapine were employed to assess the binding sites and mechanistic forms of RT interacting with UC84 and UC38.

Main Results:

  • UC38 demonstrated significantly higher inhibitory potency (IC50 = 0.8 microM) compared to UC84 (IC50 = 4.3 microM).
  • UC84 exhibited competitive inhibition with respect to P/T, while UC38 showed uncompetitive inhibition. Both were mixed noncompetitive inhibitors with respect to dNTP.
  • Both compounds protected RT from photoinactivation by a nevirapine analog, indicating binding to the nevirapine-binding region. However, UC84 protected free RT and the RT-P/T complex, whereas UC38 protected the RT-P/T-dNTP ternary complex.

Conclusions:

  • UC38 is a more potent inhibitor of HIV-1 RT than UC84.
  • UC84 and UC38 bind to distinct mechanistic forms of HIV-1 RT during the polymerase reaction, suggesting different modes of interaction and potential for combination therapy.

More Related Videos

Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors08:33

Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors

Published on: January 19, 2015

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...